OSR Health’s VXM01 Oral DNA Vaccine Shows Promise in Glioblastoma Trials, Boosting Hope for Multi‑Cancer Treatment
OSR Health’s VXM01 vaccine shows safe, dose‑dependent immune activity in glioblastoma trials and promising synergy with checkpoint inhibitors—a potential breakthrough for multiple cancers.
3 minutes to read